A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma

Summary

Activated T cell were manufactured through in vitro T cell expansion of autologous T cell. We designed this study to determine the feasibility and safety of Activated T-lymphocyte cell therapy for refractory/relapsed neuroblastoma patients.

Timeline

Start

2013-02

Primary completion

2016-06

Completion

2018-10-31

Drugs

Indications